NAPIGEN

NAPIGEN is a genome editing company specialized for mitochondrial DNA. Our business ranges from Industrial biotechnology and human healthcare to agriculture.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Wilmington, DE, USA
  • Currency USD
  • Founded August 2016
  • Employees 7
  • Incorporation Type C-corp
  • Website napigen.com

Company Summary

Mitochondrial engineering provides various opportunities to create new products. Our first product will be in agriculture: We aim to create hybrid wheat seeds to mitigate the food security problem of our society . Our approach is non-GMO and will be superb over any conventional hybrid wheat approaches. Further, our approach will be applied to other crop plants, such as rice, barley and rye, to bring their yield potentials to the next dimension.

Team

  • Hajime Sakai

  • Ganesh Kishore
    Co-Founder & Board Member

    Former Chief Biotechnologist of Monsanto and Former Chief Biotechnology Officer of DuPont.
    Board member and Chairman of several privately held & listed companies.

  • Roger Wyse
    Co-Founder, Board Member

    Former Dean at Rutgers University and Dean of Agriculture and Life Sciences at UW Madison.
    18 years as a venture capitalist investing in Agbio, Agtech, Food and Industrial Biotech.

  • Jay Keasling
    Co-Founder, Board Member

    Prof. at University of California Berkeley.
    CEO at JointBioEnergy Institute.
    Founding companies (Amyris, LS9 and Lygos).

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free